About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials in North Carolina | 303 Studies

Clinical Trials Breast CancerNorth Carolina

Breast Cancer Clinical Trials in North Carolina

Find 303 clinical trials for breast cancer near North Carolina. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in North Carolina

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 241-260 of 303 trials

CompletedRadiation Therapy During Surgery in Treating Older Women With Invasive Breast CancerRATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells. Giving radiation during surgery may be an effective treatment for breast cancer.NCT00182728·Chapel Hill, North Carolina CompletedComparison of Two Combination Chemotherapy Regimens in Treating Women With Breast CancerRATIONALE: Drugs used in chemotherapy, such as fluorouracil, epirubicin, cyclophosphamide, and doxorubicin, work in different ways to stop tumor cells from dividing so they stop…NCT00087178·Huntsville, Alabama and 605 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedStudy of the P16 Gene as a Predictor of Myelosuppression in Breast Cancer PatientsThe primary purpose of this study is to measure the association between baseline expression of the senescence effector protein p16INK4a and myelosuppression due to chemotherapy in…NCT01305954·Chapel Hill, North Carolina

RecruitingUltra Hypo-fractionated Adjuvant Whole Breast Radiation Therapy With Simultaneous Integrated Boost for Early-Stage Breast Cancer (H-ASSIST)This study evaluates the rates of radiation-specific toxicity, quality of life, and oncologic outcomes for early-stage breast cancer and ductal carcinoma in situ treated with…NCT06902311·Chapel Hill, North Carolina

CompletedTissue Expander/Implant Reconstruction: A Single-Blinded, Randomized, Controlled TrialFollowing mastectomy (removal of your breast), reconstruction of your breast(s) can be performed using tissue expanders and implants.NCT00639106·Ann Arbor, Michigan and 2 others

CompletedMRI and Mammography Before Surgery in Patients With Stage I-II Breast CancerThe purpose of this study is to test whether patients undergoing a breast MRI (magnetic resonance imaging) before breast surgery will have better results after the surgery.NCT01805076·Gilbert, Arizona and 178 others

SuspendedTesting Low Dose Tamoxifen for Invasive Breast Cancer, LoTam TrialThis phase III trial compares the effect of low dose tamoxifen to usual hormonal therapy, including aromatase inhibitors, in treating post-menopausal women with hormone positive…NCT06671912·Anchorage, Alaska and 731 others

Active not recruitingNBTXR3 Activated by Radiotherapy for Patients With Advanced Cancers Treated With An Anti-PD-1 TherapyThe 1100 study is an open-label, Phase I, dose escalation and expansion prospective clinical study to assess the safety of intratumoral injection of NBTXR3 activated by…NCT03589339·San Francisco, California and 12 others

Active not recruitingA Study of Disitamab Vedotin With Other Anticancer Drugs in Solid TumorsThis clinical trial is studying solid tumor cancers. A solid tumor is one that starts in part of your body like your lungs or liver instead of your blood.NCT06157892·Tucson, Arizona and 134 others

Active not recruitingIntraoperative Electron Beam Radiotherapy Boost in Treating Patients With Stage I-II Breast Cancer Undergoing Surgery With ReconstructionThis phase II trial studies the side effects of intraoperative electron beam radiotherapy boost and to see how well it works in treating patients with stage I-II breast cancer…NCT02927912·Chapel Hill, North Carolina and 4 others

Active not recruitingStudy of Stereotactic Radiosurgery With Olaparib Followed by Durvalumab and Physician's Choice Systemic Therapy in Subjects With Breast Cancer Brain MetastasesThis study is a Phase I/II study evaluating the safety and effectiveness of focused radiation therapy (radiosurgery) together with olaparib, followed by immunotherapy, for…NCT04711824·Birmingham, Alabama and 6 others

CompletedCisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain MetastasesThis randomized phase II trial studies how well cisplatin works with or without veliparib in treating patients with triple-negative breast cancer and/or BRCA mutation-associated…NCT02595905·Anchorage, Alaska and 809 others

Active not recruitingTolerability of the Combination of Lapatinib and Trastuzumab in Adults Age 60 or Older With HER2 Positive Locally Advanced or Metastatic Breast CancerThis phase II trial studies the side effects and how well lapatinib ditosylate and trastuzumab work in treating older patients with human epidermal growth factor receptor 2…NCT01273610·Duarte, California and 7 others

CompletedRadiation Therapy in Treating Women With Stage I or Stage II Breast CancerRATIONALE: Radiation therapy may kill any tumor cells remaining after surgery.NCT00002873·Birmingham, Alabama and 231 others

CompletedRadiation Therapy (WBI Versus PBI) in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast CancerRATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells. Giving radiation therapy in different ways may kill any tumor cells that remain after surgery.NCT00103181·Birmingham, Alabama and 386 others

RecruitingROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast CancerThis is a Phase III trial where participants will be randomized to two treatment groups, which means participants will be assigned by equal chance to a treatment group.NCT07173751·Springdale, Arkansas and 201 others

CompletedChemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast CancerRATIONALE: Studying how older women make treatment decisions and how these decisions affect the outcome of treatment may help doctors plan more effective treatments and improve…NCT00068328·Mountain View, California and 84 others

Active not recruitingSacituzumab Govitecan +/- Pembrolizumab In HR+ / HER2 - MBCThis research study is evaluating the safety and effectiveness of Sacituzumab Govitecan with or without Pembrolizumab in metastatic HR+/HER2- breast cancer.NCT04448886·Atlanta, Georgia and 7 others

Active not recruitingMRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In SituThis clinical trial studies magnetic resonance imaging (MRI) and gene expression in diagnosing patients with abnormal cells in the breast duct that have not spread outside the…NCT02352883·San Diego, California and 75 others

Active not recruitingDocetaxel or Paclitaxel in Reducing Chemotherapy-Induced Peripheral Neuropathy in African American Patients With Stage I-III Breast CancerThis phase II trial studies how well docetaxel or paclitaxel work in reducing chemotherapy-induced peripheral neuropathy in African American patients with stages I-III breast…NCT04001829·Birmingham, Alabama and 481 others

PreviousPage 13 of 16Next

Other Conditions in North Carolina

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma